Log in

ASX:RVSRevasum Cdi 1:1 US Prohibited Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: A$0.63
52-Week Range N/A
Volume10,526 shs
Average VolumeN/A
Market Capitalization$25.76 million
P/E RatioN/A
Dividend YieldN/A
Revasum, Inc. designs, develops, manufactures, and markets a portfolio of semiconductor processing equipment worldwide. The company offers grinding, polishing, and chemical mechanical planarization equipment to manufacture microchips, sensors, LEDs, and RF and power devices, which are used in IoT devices, cellphones, wearables, automotive, and 5G and industrial applications. It also provides wafer processing equipment for device and substrate manufacturing; and spare parts kits, on-site and off-site training, and training services. Revasum, Inc. was founded in 2016 and is headquartered in San Luis Obispo, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.12 out of 5 stars

Industry, Sector and Symbol

Industry Semiconductor Equipment & Materials



Sales & Book Value

Annual Sales$20.51 million
Book ValueA$0.27 per share



Market Cap$25.76 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RVS News and Ratings via Email

Sign-up to receive the latest news and ratings for RVS and its competitors with MarketBeat's FREE daily newsletter.

Revasum Cdi 1:1 US Prohibited (ASX:RVS) Frequently Asked Questions

Has Revasum Cdi 1:1 US Prohibited been receiving favorable news coverage?

News stories about RVS stock have been trending negative on Sunday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Revasum Cdi 1:1 US Prohibited earned a news impact score of -2.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news about Revasum Cdi 1:1 US Prohibited.

Who are some of Revasum Cdi 1:1 US Prohibited's key competitors?

Who are Revasum Cdi 1:1 US Prohibited's key executives?

Revasum Cdi 1:1 US Prohibited's management team includes the following people:
  • Mr. Jerauld J. Cutini, Exec. Chairman, Pres & CEO (Age 60)
  • Mr. Ryan A. Benton, Sr. VP, CFO, Company Sec. & Exec. Director (Age 48)
  • Mr. David Roeloffs, VP of Operations
  • Dr. Robert Rhoades, Chief Technology Officer
  • Ms. Sarah Okada, VP of Marketing & Product Management

What is Revasum Cdi 1:1 US Prohibited's stock symbol?

Revasum Cdi 1:1 US Prohibited trades on the ASX under the ticker symbol "RVS."

How big of a company is Revasum Cdi 1:1 US Prohibited?

Revasum Cdi 1:1 US Prohibited has a market capitalization of $0.00 and generates $20.51 million in revenue each year. Revasum Cdi 1:1 US Prohibited employs 106 workers across the globe.

What is Revasum Cdi 1:1 US Prohibited's official website?

The official website for Revasum Cdi 1:1 US Prohibited is www.revasum.com.

How can I contact Revasum Cdi 1:1 US Prohibited?

The company can be reached via phone at 805-541-6424.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.